Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TRHR | P34981 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9719683 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL26508302 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL19875638 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL31199181 | 0.95 | NTSR2 (0.44) | ALDH1A1MEN1LMNAKMT2AHDAC3 | |
| SCHEMBL26508387 | 0.95 | NTSR2 (0.44) | ALDH1A1MEN1LMNAKMT2AHDAC3 | |
| SCHEMBL31199084 | 0.89 | NTSR2 (0.39) | ALDH1A1MEN1LMNAKMT2AHDAC3 | |
| SCHEMBL25834350 | 0.89 | HDAC3 (0.41) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL10359347 | 0.88 | TRHR (0.42) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL28864215 | 0.88 | TRHR (0.42) | TRHRHDAC3HDAC11HDAC6HDAC1 | |
| SCHEMBL19359174 | 0.88 | TRHR (0.42) | TRHRHDAC3HDAC11HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439941-B2 | Flavor composition and edible compositions containing same | MARS, INCORPORATED (US) | 2025-10-14 | — | — | US | claimed |
| US-20240373884-A1 | FLAVOR COMPOSITION AND EDIBLE COMPOSITIONS CONTAINING SAME | MARS, INCORPORATED (US) | 2024-11-14 | — | — | US | claimed |
| WO-2022181712-A1 | COMPOSITION CONTAINING DECOMPOSED PRODUCTS OF VEGETABLE PROTEIN AND METHOD FOR PRODUCING SAME | 株式会社Mizkan Holdings | 2022-09-01 | — | — | WO | claimed |
| EP-0373904-A1 | Process and composition for increasing brain dopamine release | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-06-20 | — | — | EP | claimed |
| US-20260000096-A1 | FLAVOR COMPOSITION AND EDIBLE COMPOSITIONS CONTAINING SAME | MARS, INCORPORATED (US) | 2026-01-01 | — | — | US | disclosed |
| US-12439941-B2 | Flavor composition and edible compositions containing same | MARS, INCORPORATED (US) | 2025-10-14 | — | — | US | disclosed |
| US-12285037-B2 | Flavor composition and edible compositions containing same | MARS, INCORPORATED (US) | 2025-04-29 | — | — | US | disclosed |
| US-20240373884-A1 | FLAVOR COMPOSITION AND EDIBLE COMPOSITIONS CONTAINING SAME | MARS, INCORPORATED (US) | 2024-11-14 | — | — | US | disclosed |
| WO-2024225153-A1 | IMMUNOACTIVATING COMPOSITION | サントリーホールディングス株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024225151-A1 | LEGUME-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME, AND CHICKEN GIZZARD-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME | サントリーホールディングス株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024225151-A1 | LEGUME-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME, AND CHICKEN GIZZARD-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME | サントリーホールディングス株式会社 | 2024-10-31 | — | — | WO | disclosed |
| CN-116531349-A | Polyamino acid drug-loaded nano-particle with redox responsiveness and preparation method thereof | 宁德师范学院 | 2023-08-04 | — | — | CN | disclosed |
| US-5118670-A | PROCESS AND COMPOSITION FOR INCREASING BRAIN DOPAMINE RELEASE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-06-02 | — | — | US | disclosed |
| US-4940816-A | Acylated cyanamide compounds | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1990-07-10 | — | — | US | disclosed |
| EP-0253882-A4 | ACYLATED CYANAMIDE COMPOSITION. | UNIV MINNESOTA (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0373904-A1 | Process and composition for increasing brain dopamine release | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-06-20 | — | — | EP | disclosed |
| US-4870056-A | DETERRENTS OF ALCOHOL ABUSE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1989-09-26 | — | — | US | disclosed |
| US-4726941-A | Acylated cyanamide composition for treating ethanol ingestion | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1988-02-23 | — | — | US | disclosed |
| EP-0253882-A1 | ACYLATED CYANAMIDE COMPOSITION | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1988-01-27 | — | — | EP | disclosed |
| WO-1987004348-A1 | ACYLATED CYANAMIDE COMPOSITION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1987-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000096-A1 | FLAVOR COMPOSITION AND EDIBLE COMPOSITIONS CONTAINING SAME | SLC6A19, QPCTL, PTMS | ALDH1A1 4167/4885MEN1 324/4885LMNA 4445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.